Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-09 6:40 pm Purchase | 2024-05-07 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 36,669,079 16.300% | 27,617 (+0.08%) | Filing History |
| 2024-04-23 4:25 pm Purchase | 2024-04-19 | 13D | TSCAN THERAPEUTICS INC TCRX | Baker Bros. Advisors LP | 2,828,938 6.100% | 35,000 (+1.25%) | Filing History |
| 2024-04-18 07:29 am Purchase | 2024-04-16 | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | Baker Bros. Advisors LP | 7,689,243 19.900% | 2,865,645 (+59.41%) | Filing History |
| 2024-04-01 08:57 am Purchase | 2024-03-28 | 13D | KYMERA THERAPEUTICS INC KYMR | Baker Bros. Advisors LP | 5,997,706 9.800% | 1,778 (+0.03%) | Filing History |
| 2024-03-28 7:13 pm Purchase | 2024-03-28 | 13D | IGM BIOSCIENCES INC IGMS | Baker Bros. Advisors LP | 4,145,706 12.400% | 401,037 (+10.71%) | Filing History |
| 2024-03-25 4:28 pm Purchase | 2024-03-21 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | Baker Bros. Advisors LP | 2,070,544 9.990% | 82,842 (+4.17%) | Filing History |
| 2024-03-05 4:24 pm Purchase | 2024-02-27 | 13D | VTV THERAPEUTICS INC VTVT | Baker Bros. Advisors LP | 122,664 4.990% | 122,664 (New Position) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | 2SEVENTY BIO INC TSVT | Baker Bros. Advisors LP | 2,527,672 4.990% | 464,928 (+22.54%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | ABCELLERA BIOLOGICS INC. ABCL | Baker Bros. Advisors LP | 22,909,753 7.900% | 22,909,753 (New Position) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | ACHILLES THERAPEUTICS PLC ACHL | Baker Bros. Advisors LP | 3,311,567 8.100% | -896,166 (-21.30%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | INOZYME PHARMA INC INZY | Baker Bros. Advisors LP | 0 0.000% | -2,168,000 (Position Closed) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | ZYMEWORKS INC ZYME | Baker Bros. Advisors LP | 27,000 0.040% | -3,787,196 (-99.29%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | MIRATI THERAPEUTICS INC MRTX | Baker Bros. Advisors LP | 0 0.000% | -1,995,200 (Position Closed) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | Baker Bros. Advisors LP | 65,815,692 4.800% | 6,830,430 (+11.58%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | Baker Bros. Advisors LP | 48,015 6.100% | -8,467 (-14.99%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Baker Bros. Advisors LP | 0 0.000% | -255,361 (Position Closed) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | ALIGOS THERAPEUTICS INC ALGS | Baker Bros. Advisors LP | 146,561 4.990% | 63,505 (+76.46%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | VERSARTIS INC ARAV | Baker Bros. Advisors LP | 3,863,568 4.990% | -722,836 (-15.76%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | CABALETTA BIO INC CABA | Baker Bros. Advisors LP | 1,457,626 3.400% | 113,626 (+8.45%) | Filing History |
| 2024-02-14 4:21 pm Unchanged | 2023-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Baker Bros. Advisors LP | 2,368,378 4.300% | 0 (Unchanged) | Filing History |